AFUA GYAMFI: Open Payments
NPI 1225690266 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 9 payments from 6 companies in 2025. Trend: 2023 $1,058 · 2024 $51 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 1 | $150 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Lilly USA, LLC | 2 | $42 |
| Deciphera Pharmaceuticals Inc. | 1 | $28 |
| Stemline Therapeutics Inc. | 1 | $18 |
Products named: TEVIMBRA, KISQALI, VERZENIO, QINLOCK, KEYTRUDA QLEX, KEYTRUDA, Orserdu.
Industry payments across NY — which companies pay providers there.
